Wei‐Cheng Lin
Papers
1
Total Citations
3
H-Index
1
About
Dr. Wei-Cheng Lin is pioneering the use of ingestible capsule technology for critical care monitoring, with a primary focus on intra-abdominal pressure (IAP) assessment. His landmark work, "Feasibility and accuracy of continuous intraabdominal pressure monitoring with a capsular device in human pilot trial" (2025), addresses a life-threatening gap in clinical medicine: the early detection of intra-abdominal hypertension and abdominal compartment syndrome. By demonstrating that a swallowable capsule can provide continuous, accurate IAP readings, Lin’s research offers a non-invasive alternative to traditional catheter-based methods, potentially transforming how clinicians monitor at-risk patients. This innovation, already garnering early citations, builds on his broader expertise in gastrointestinal diagnostics and medical device development. Lin’s contributions are particularly significant for intensive care and surgical settings, where timely intervention can prevent organ failure. His work exemplifies the convergence of biomedical engineering and bedside medicine, promising to make continuous IAP monitoring safer, more accessible, and less burdensome for patients.
Research Focus
Key Achievements
Top Papers
- 1